News Features A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity Yael L. Maxwell October 24, 2016
News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016
News Daily News Sitting Pretty: Only Prolonged Sedentary Time Linked With Incident CVD Risk Michael O'Riordan July 15, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016